Abstract. Bovine chromaffin cells have binding sites for rat atrial natriuretic factor (ANF), as demonstrated autoradiographically by using the ~2SI-labelled peptide. Patch-clamp recording revealed that ANF reduces acetylcholine (ACh)-induced membrane currents in chromaffin cells at physiological membrane potentials. The effect was dose-dependent with the ICs0 value being 5.2 pM ANF and the Hill coefficient close to 1. The channel block was absent at positive membrane potentials, indicating a non-competitive interaction of ANF with the open ACh receptor channel. Fragments of ANF had a much less pronounced action, which is possibly due to their structure and molecular charge being different to ANF. The block of nicotinic ACh receptor channels may enable ANF to control the secretion of catecholamines from adrenal chromaffin cells.
Introduction
Atrial natriuretic factor (ANF), a peptide with natriuretic, diuretic and vasorelaxatory properties, is primarily produced and secreted from mammalian atria (see Genest and Cantin 1988 for review) . One of its target organs is the adrenal gland where the peptide inhibits aldosterone secretion from the zona glomerulosa cells (Chartier et al. 1984; Atarashi et al. 1984) . A physiological influence of the peptide on adrenomedullary cells was indicated by data showing that human ANF binds to human pheochromocytoma cells, where it decreases catecholamine synthesis (Shionoiri et al. 1987) . Binding sites for ANF have also been demonstrated autoradiographically in the adrenal medulla of tree shrews and primates (Fuchs et al. 1985 (Fuchs et al. , 1986 .
Although the synthesis of ANF in bovine chromaffin cells was recently demonstrated (Pruss and Zamir 1987; Ong et al. 1987; Mukoyama et al. 1988) , reports on the presence of binding sites for the peptide in the bovine adrenal medulla are inconsistent (Higuchi et al. 1986; Heisler and Morrier 1988) . We therefore looked for the binding of rat ANF ] to intact bovine adrenal chromaffin cells rather than to isolated membranes (Heisler and Morrier 1988) or to dried tissue slices (Higuchi et al. 1986 ).
The occurrence of ANF in the adrenal medulla has been tentatively ascribed to a role in controlling the acetylcholine (ACh)-mediated secretion of catecholamines (Morel et al. 1988) . In order to address this issue, we carried out patchclamp experiments on cultured chromaffin cells. We used the whole-cell configuration of the patch-clamp technique (Hamill et al. 1981) and studied the effect of ANF on nicotinic ACh receptor channels.
Materials and methods
Cell culture. Chromaffin cells were prepared from bovine adrenal medullae as previously described (Fenwick et al. 1982) and plated on glass cover-slips. Cells were used 1 day after culturing.
Autoradiography. Cells were washed in buffer (50 mM Tris-HC1 pH 7.4, 100 mM NaC1, 5 mM MgC12, 0.5% bovine serum albumin, 40 gg/ml bacitracin, 4 lag/ml leupeptin, 2 gg/ml chymostatin, 0.5 gg/ml phenylmethylsulfonylfluoride) and than labelled by incubating for 45 rain in the same buffer to which 2 nM (3-[125I]-iodotyrosilZ8) ANF (specific activity 2,000 Ci/mmol, Amersham, Braunschweig, FRG) had been added. The incubation was carried out according to Quirion et al. (1984) . Unspecific binding was detected in the presence of a thousandfold excess of unlabelled ANF. Following the last washing step, the coverslips with cells were dipped into. 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.2, for 2 min, washed in distilled water, and dried under a cold stream of air. They were then covered with photographic emulsion (NTB 3, Eastman Kodak, Rochester, NY, USA) and exposed for 10 days. After photographic development with D19 and Unifix (Eastman, Kodak, Rochester, NY, USA), cells were stained with hematoxylin, mounted in Eukitt, and inspected under a Zeiss light microscope. recorded by means of a standard patch-clamp amplifier (EPC-7, List-Electronic, Darmstadt, FRG) and stored on video tape for later analysis. ANF and its fragments were purchased from Peninsula Laboratories (Belmont, CA, USA) and all other compounds from Sigma (Miinchen, FRG). The stability of ANF in the perifusion solution was tested with the instant radioreceptor assay for atrial natriuretic factor (ANAWA Laboratories, Wangen, Switzerland). This assay detects the physiologically active form of ANF which binds to bovine adrenal cortex ANF receptor. ANF dissolved in our HEPES buffer remained in this biologically active form for at least 4 h.
Results
The presence of ANF binding sites in bovine chromaffin cells is illustrated in Fig. 1 , showing an autoradiogram of cultured cells incubated with 125I-ANF. Silver grains, which indicate binding of the peptide, are distributed over the cell. In the vicinity, several unlabelled cells are visible. Figure 2A shows whole-cell currents activated by the application of 10 ktM ACh to a chromaffin cell, held at -70 mV membrane potential. With 4 ktM ANF included in the ACh solution, the peak-current response to ACh was changed from 100 pA to 53 pA, i.e. a reduction of 47%. From 10 experiments, the average ratio (_+ SD) of currents in presence and absence of ANF was 0.51 + 0.03 (range 0.46-0.56). The effect of ANF was readily reversible as seen after applying ACh alone 2 min later. With 20 gM ACh, a comparable reduction of the ACh-induced current was found (Fig. 2 B) , indicating that ANF may not directly interact with the ACh receptor. In this case, the current ratio was 0.59 +_ 0.04 (range 0.52--0.63, n = 7).
The concentration dependence of the ANF effect is illustrated in Fig. 3 (
Based on this scheme, we have fitted a theoretical curve to the data, as has been reported elsewhere to describe the block of ion channels by drugs (Trube et al. 1986; OhnoShosaku et al. 1987) :
which is equivalent to
From the fit of the 10 ~tM-ACh data, we obtained a binding constant K for ANF of 36 ~tM and a Hill coefficient of 0.84, corresponding to an IC50 value of 5.2 gM.
Rat-ANF is a peptide with a positive molecular net charge. If this were causing its blocking action on ACh receptor channels at negative membrane potentials, the effect should be voltage dependent. We therefore measured the ANF ratio, I/Ic, as a function membrane potential. Figure 4 shows the data obtained in the voltage range from -100 mV to + 50 inV. The reduction of ACh-induced currents by 4 gM ANF was particularly pronounced at very negative membrane potentials. The peptide became less effective upon depolarizing the cells. At positive voltages, ANF was virtually devoid of any action, again supporting the idea of a direct channel block by the peptide.
The block of nicotinic ACh receptor channels by ANF may, however, not be specific to this channel. We therefore tested the peptide on the GABA receptor channel, a C1--channel which is also present on chromaffin cells (Bormann and Clapham 1985) . ANF did not significantly affect GABA-activated whole-cell currents over a wide range of membrane voltages, indicating that ANF may block specifically the ACh-operated cation channel in bovine chromaffin cells.
Finally, in an attempt to study the structural determinants which cause this block, we used several commercially available peptides each of which constitute part of the amino acid sequence of ANF. We have tested the biological active fragment ANF (103--126) (Atriopeptin II), and the truncated biologically inactive fragments ANF (99-109) and ANF (116-126). Table 1 shows the I/I~ ratios in comparison to ANF for all peptides applied at 10 gM concentration in 10 gM ACh solutions. The action of the three smaller ANF fragments was less pronounced than that of ANF (99-126), which may be related to their different structure. In addition, the net charge of the peptides resulting from the unbalance of basic and acidic amino acids, may be important. In contrast, human Angiotensin II, a peptide unrelated to ANF, showed only a very weak action on ACh receptor channels (Table 1) . 
Discussion
The purpose of the experiments described was twofold. Firstly, we wanted to investigate whether binding sites, which have been demonstrated autoradiographically on dried sections of the adrenal medulla of certain species (Fuchs et al. 1985 (Fuchs et al. , 1986 , also exist on living bovine (Higuchi et al. 1986 ) excluded the presence of ANF binding sites. However, an interaction could still take place at the level of ionic channels, which function normally only in living cells.
Patch-clamp experiments demonstrated that ANF is capable of reducing the activity of nicotinic ACh receptor channels in bovine chromaffin cells. These channels are closely associated with the nerve-stimulated release of catecholamines from adrenal medulla. The decrease of the current flowing through ACh receptor channels by ANF was concentration-dependent with the half-maximal concentration being 5.2 gM ANF and the Hill coefficient close to 1. From the voltage-dependence, the block of ACh receptor channels appeared to be non-competitive. A similar mechanism has been described for several drugs acting as blockers of the nicotinic ACh receptor channel (Adams 1981) . As to the molecular determinants of the ANF block, both the structure and charge of the peptide may contribute to its effect. Anion channels like the GABA-operated C1--channel were not influenced by ANF, indicating a specific interaction of the peptide with cationic ACh receptor channels.
Recently, the synthesis and the release of ANF from rat and bovine adrenomedullary chromaffin cells was demonstrated (Pruss and Zamir 1987; Mukoyama et al. 1988 ). However, the peptide's physiological role in the adrenal medulla is not yet clear. Our data suggest a participation of ANF in the inhibitory control of catecholamine secretion from chromaffin cells. This assumption is supported by earlier reports on an inhibitory effect of ANF in the sympathetic nervous system Debinski et al. 1987) . A new aspect in the understanding of the physiological function is the finding, that the peptide may not only act by a classic ligand-receptor interaction but also by blocking nicotinic ACh receptor channels. This suggests the existence of a complex paracrine regulation not only of the catecholamine secretory process but also of the release of a variety of other bioactive peptides present in adrenal chromaffin cells such as enkephalins, dynorphin, somatostatin, VIP and others.
